Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis. (Q34168304)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis. |
scientific article |
Statements
Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis (English)
D F Easton
S M Edwards
Q Hope
A R Norman
Y Barbachano
S Bullock
J Meitz
A Falconer
P Osin
C Fisher
M Guy
S G Jhavar
A L Hall
L T O'Brien
B N Gehr-Swain
R A Wilkinson
D P Dearnaley
A T Ardern-Jones
E C Page
UK Genetic Prostate Cancer Study Collaborators and BAUS Section of Oncology
24 August 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference